Multihospital outbreak of clostridium difficile infection, Cleveland, Ohio, USA

Emerging Infectious Diseases

Volumn 16, Issue 5, 2010, Pages 827-829

  Jump, Robin L P ^a   Riggs, Michelle M ^b   Sethi, Ajay K ^c   Pultz, Michael J ^b   Ellis Reid, Tracie ^b   Riebel, William ^d   Gerding, Dale N ^e,f   Salata, Robert A ^a   Donskey, Curtis J ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Lakewood Hospital   (United States)

^e HINES VA HOSPITAL   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DRUG USE; EPIDEMIC; FECES ANALYSIS; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RATE; NONHUMAN; UNITED STATES;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FECES; FLUOROQUINOLONES; GENES, BACTERIAL; HOSPITALS; HUMANS; OHIO; QUINOLINES;

EID: 77951174494     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1605.071606     Document Type: Article

References (14)

1. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-41. DOI: 10.1056/NEJMoa051590
2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442-9. DOI: 10.1056/NEJMoa051639
3. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fl uoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273-80. DOI: 10.1086/502539
4. Yip C, Loeb M, Salama S, Moss L, Olde J. Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol. 2001;22:572-5. DOI: 10.1086/501954
5. McCusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis. 2003;9:730-3.
6. Gaynes R, Rimland D, Killum E, Lowery K, Johnson TM, Kilgore G, et al. Outbreak of Clostridium difficile infection in a longterm care facility: association with gatifl oxacin use. Clin Infect Dis. 2004;28:640-5. DOI: 10.1086/381551
7. Pepin J, Saheb N, Coulombe M, Alary ME, Corriveau MP, Authier S, et al. Emergence of fl uoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-60. DOI: 10.1086/496986
8. Biller P, Shank B, Lind L, Brennan M, Tkatch L, Killgore G, et al. Moxifl oxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol. 2007;28:198-201. DOI: 10.1086/511789
9. von Baum H, Sigge A, Bommer M, Kern WV, Marre R, Dohner H, et al. Moxifl oxacin prophylaxis in neutropenic patients. J Antimicrob Chemother. 2007;58:891-4. DOI: 10.1093/jac/dkl320
10. Adams DA, Riggs MM, Donskey CJ. Effect of fl uoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice. Antimicrob Agents Chemother. 2007;51:2674-8. DOI: 10.1128/AAC.01582-06
11. Al-Nassir W, Riggs MM, Bobulsky G, Donskey CJ. A comparison of clinical and microbiological response to therapy of Clostridium difficile infection with metronidazole versus vancomycin. Clin Infect Dis. 2008;47:56-62. DOI: 10.1086/588293
12. Terhes G, Urban E, Soki J, Hamid KA, Nagy E. Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol. 2004;42:4316-8. DOI: 10.1128/JCM.42.9.4316-4318.2004
13. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile isolates. J Clin Microbiol. 2002;40:3470-5. DOI: 10.1128/JCM.40.9.3470-3475.2002
14. Fraser T, Fatica C, Gordon SM. Public reporting of Clostridium difficile associated diarrhea (CDAD): in-house vs. mandated definitions. In: Abstracts of the 17th Annual Scientific Meeting of The Society for Healthcare Epidemiology of America; Baltimore, Maryland; 2007 April 14-17; Abstract 168. Arlington (VA): Society for Healthcare Epidemiology of America; 2007.